← Back
$AMLX All transactions

Amylyx Pharmaceuticals, Inc.

▼ SELL

$ Value

$424K

Shares

29,282

Price

$14

Filed

Mar 4

Insider

Name

Klee Justin B.

Title

Co-Chief Executive Officer

CIK

0001898314

Roles

Director Officer

Transaction Details

Transaction Date

2026-03-02

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

3,334,616

Footnotes

Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.450 to $15.360. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Filing Info

Accession No.

0001193125-26-091443

Form Type

4

Issuer CIK

0001658551

Klee Justin B.'s History

Date Ticker Type Value
2026-03-05 AMLX A $0
2026-03-05 AMLX A $0
2026-03-02 AMLX $424K
2026-02-02 AMLX $228K
2026-01-16 AMLX M $22K
2026-01-16 AMLX $28K
2026-01-16 AMLX M $0
2026-01-15 AMLX M $1.5M
2026-01-15 AMLX $1.8M
2026-01-15 AMLX M $0

Other Insiders at AMLX (90d)

Insider Bought Sold Last
FRATES JAMES M
Chief Financial Officer
$167K 2026-03-05
Bedrosian Camille L
Chief Medical Officer
$94K 2026-03-05
Klee Justin B.
Co-Chief Executive Officer
$228K 2026-03-05
Cohen Joshua B
Co-Chief Executive Officer
$652K 2026-03-05
Mazzariello Gina
Chief Legal Officer
$198K 2026-03-05